Natixis Trims Holdings in Amedisys, Inc. (NASDAQ:AMED)

Natixis trimmed its stake in Amedisys, Inc. (NASDAQ:AMED) by 13.1% during the first quarter, according to its most recent 13F filing with the SEC. The firm owned 106,218 shares of the health services provider’s stock after selling 15,984 shares during the period. Natixis owned about 0.33% of Amedisys worth $9,789,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also made changes to their positions in AMED. Retirement Systems of Alabama grew its holdings in shares of Amedisys by 0.3% in the fourth quarter. Retirement Systems of Alabama now owns 40,871 shares of the health services provider’s stock valued at $3,885,000 after purchasing an additional 125 shares in the last quarter. Treasurer of the State of North Carolina grew its holdings in shares of Amedisys by 1.0% in the fourth quarter. Treasurer of the State of North Carolina now owns 14,204 shares of the health services provider’s stock valued at $1,350,000 after purchasing an additional 140 shares in the last quarter. Louisiana State Employees Retirement System grew its holdings in Amedisys by 2.2% during the 1st quarter. Louisiana State Employees Retirement System now owns 9,400 shares of the health services provider’s stock worth $866,000 after acquiring an additional 200 shares in the last quarter. Bridge City Capital LLC grew its holdings in Amedisys by 0.8% during the 1st quarter. Bridge City Capital LLC now owns 29,861 shares of the health services provider’s stock worth $2,752,000 after acquiring an additional 231 shares in the last quarter. Finally, Mesirow Institutional Investment Management Inc. grew its holdings in Amedisys by 9.9% during the 4th quarter. Mesirow Institutional Investment Management Inc. now owns 2,844 shares of the health services provider’s stock worth $270,000 after acquiring an additional 257 shares in the last quarter. 94.36% of the stock is owned by hedge funds and other institutional investors.

Amedisys Stock Up 0.2 %

Shares of Amedisys stock traded up $0.17 during trading hours on Thursday, hitting $97.75. The company had a trading volume of 404,324 shares, compared to its average volume of 315,304. The company’s 50-day moving average is $94.81 and its two-hundred day moving average is $93.79. Amedisys, Inc. has a twelve month low of $89.55 and a twelve month high of $98.46. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.09 and a quick ratio of 1.09. The company has a market cap of $3.19 billion, a P/E ratio of -152.73, a price-to-earnings-growth ratio of 2.40 and a beta of 0.79.

Amedisys (NASDAQ:AMED) last issued its earnings results on Wednesday, April 24th. The health services provider reported $1.03 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.02 by $0.01. Amedisys had a negative net margin of 0.91% and a positive return on equity of 12.85%. The business had revenue of $571.41 million during the quarter, compared to analysts’ expectations of $565.38 million. During the same quarter in the prior year, the business posted $1.00 EPS. The company’s revenue for the quarter was up 2.7% on a year-over-year basis. Analysts anticipate that Amedisys, Inc. will post 4.57 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several research analysts have commented on the stock. William Blair cut shares of Amedisys from an “outperform” rating to a “market perform” rating in a report on Monday, July 1st. Cantor Fitzgerald reiterated a “neutral” rating and set a $101.00 price target on shares of Amedisys in a report on Thursday. Finally, StockNews.com upgraded shares of Amedisys from a “hold” rating to a “buy” rating in a report on Saturday, May 4th. Four analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. According to MarketBeat, the stock has an average rating of “Hold” and an average target price of $100.67.

Amedisys Company Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.